why shares of bellus health skyrocketed this week. what happened shares of bellus health (nasdaq: blu) jumped 105.1% this week as of thursday afternoon according to data provided by s&p global market intelligence. the company which received a $

bellus health (blu) stock up 99% on $2b buyout offer from gsk. bellus healthblu and gsk plc gsk announced that the former got an offer to be acquired by the latter for $14.75 per share of common stock in cash representing an approximat

canada stocks-toronto market extends winning streak on soft landing hopes. canadas main stock market rose on tuesday to its highest closing level in two months as easing inflation raised prospects of the domestic economy avoiding recession and s

canada stocks-tsx tracks best winning streak since jan. bellus health soars. canadian stocks rose on tuesday after consumer price data showed signs of slowing inflation while shares of bellus health nearly doubled on gsks buyout deal.

why bellus health stock is rocketing higher today. what happened shares of bellus health (nasdaq: blu) were up by a whopping 98.9% as of 10:19 a.m. et tuesday morning. the big gain came in response to a $2 billion buyout agreement with british

bellus health soars 98% as gsk joins buyout bonanza with $2 billion deal.

canada stocks-precious metal miners lift tsx higher. bellus health soars. canadas main stock opened higher on tuesday supported by gains in precious metal miners on better-than-forecast growth data from china while shares of bellus health nearly

gsk to strengthen specialty medicines and respiratory pipeline with $2b bellus health acquisition. ) has agreed tothe late-stage biopharmaceutical company

bellus health sunrun and other big stocks moving higher in tuesdays pre-market session. United States stock futures traded higher this morning. here are some big stocks recording gains in today&rsquo.s pre-market trading session. ) shares jumped 97.5%

gsk to buy bellus health in us$2.0 bln deal. (rttnews) - gsk plc (gsk gsk.l) agreed to buy bellus health inc. (blu blu.to) a canada-based late-stage biopharmaceutical company working to better the lives of patients suffering from refractory chro

gsk to buy canadas bellus health for $2 bln. gsk plc will buy canada-based late-stage biopharma company bellus health inc in an all-cash deal for $2 billion the companies said in a joint statement on tuesday.

heres why bellus (blu) is poised for a turnaround after losing -15.33% in 4 weeks. a downtrend has been apparent in bellus health (blu) lately with too much selling pressure. the stock has declined 15.3% over the past four weeks. howev

bellus: phase 1 study establishes proof of concept for developing er formulation of camlipixant. (rttnews) - bellus health inc. (blu blu.to) reported positive data from its phase 1 bioavailability equivalence study evaluating a once-daily extend